For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Poitiers 86021

0 studies enrolling now · 11 studies all time

What they study most

Acute Coronary Syndrome, Alzheimer's Disease, Back Pain, Colorectal Cancer, Diabetes Mellitus, Type 1, Glioblastoma, Non Small Cell Lung Cancer, Osteoporosis, Postmenopausal, Psoriasis, Rheumatoid Arthritis, Sepsis, Severe Sepsis

Studies at this site

• A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer — Running, not enrolling
• A Phase 3 Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2) — Completed
• A Study in Second Line Metastatic Colorectal Cancer — Completed
• A Study in Moderate to Severe Rheumatoid Arthritis — Completed
• Enzastaurin Versus Lomustine in Glioblastoma — Completed
• Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes — Completed
• Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With Placebo — Completed
• A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects — Completed
• Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic Shock — Completed
• Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis — Completed
• Evaluate Protein C Levels in Severe Sepsis Patients on Drotrecogin Alfa (Activated) — Completed